hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang上一页:癫痫治疗 中医治疗癫痫不用担心
下一页:预测癫痫患者再入院风险
- 2022-04-28昏迷的疾病 昏迷如何护理
- 2022-04-21隐源性癫痫患病率翻倍
- 2022-04-13癫痫定位新方法:无框架立体定向脑电图技术
- 2022-04-11UCB的Vimpat癫痫新适应症在美国获批
- 2022-04-11第四届全国临床脑电图实践基础理论与实践操作培训班
- 2022-04-07北京哪家癫痫医院排名好,成本低
- 综述:癫痫持续状态诊治最新进展
- UCB的Vimpat癫痫新适应症在美国获批
- 第四届全国临床脑电图实践基础理论与实践操作培训班
- 北京哪家癫痫医院排名好,成本低
- 癫痫患者手术评估新型工具
- 癫痫患者停药问题解决了吗?最新的预测模型已经发布!
- FDA批准Aptiom用于治疗患者癫痫发作
- 癫痫治疗障碍仍难以克服
- 泡温泉时不能忽视的事情
- 黑芝麻的营养价值 吃黑芝麻的好处
- Neurology:颅脑损伤增加了迟发性癫痫的风险,高损伤频率、重伤、老年人尤其是
- 月经性癫痫患者妊娠期癫痫控制更好
- 罕见病例:自发性颞极性扩张伴癫痫发作
- 抗癫痫药物预防新发癫痫:任重而道远
- 惊厥性癫痫持续状态如何正确用药?最新共识告诉你
- 三庚酸酯可治疗1型转运体缺陷综合征
- 羊角病能生孩子吗?
- 不注意这些问题,吃多少药都没用!
- 38癫痫患者年病史上的感谢信 道出了浓浓的医患情况
- 特发性癫痫大发作药物治疗的首选
- NeuroImage:纤维球成像可用于癫痫的进展
- 癫痫猝死:凶手是谁?
- Medpage Today:不同类型的抗癫痫药物更有利
- 预测癫痫患者再入院风险
- 2013国际抗癫痫联合会抗癫痫药用指南
- 癫痫治疗 中医治疗癫痫不用担心
- 2016AAN:神经专家发表了有前途的专业见解
- 大连癫痫病医院治疗费用是多少
- 女性检查 定期检查摆脱妇科亚健康
- 孕妇能吃方便面吗 食用方便面过度危害大(2)
- 不伴颞叶内侧愈合的颞叶癫痫患者隔核增大
- NeuroImage:纤维球成像可用于高血压疾病进展
- 得了发作会有什么症状
- 癫痫病的疾病有哪些
- Circ Ep:腺苷试验可鉴别复发AF消融术时的隐匿诱导静脉
- 癫痫病的外科手术费用
- 蔬果虽难看可能更健康
- 高温瑜伽 应该如何正确锻炼高温瑜伽
- FDA 批准首个含活性成分的药物用于治疗罕见确实癫痫
- 世界抑郁症日 | 科学防治 规范诊疗 告别抑郁症